Proposed Data Collection Submitted for Public Comment and Recommendations, 61750-61752 [2020-21621]

Download as PDF 61750 Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your comment or supporting materials that you consider confidential or inappropriate for public disclosure. If you include your name, contact information, or other information that identifies you in the body of your comments, that information will be on public display. ATSDR will review all submissions and may choose to redact, or withhold, submissions containing private or proprietary information such as Social Security numbers, medical information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. ATSDR will carefully consider all comments submitted in preparation of the final Toxicological Profile and may revise the profile as appropriate. jbell on DSKJLSW7X2PROD with NOTICES Legislative Background The Superfund Amendments and Reauthorization Act of 1986 (SARA) [42 U.S.C. 9601 et seq.] amended the Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (CERCLA or Superfund) [42 U.S.C. 9601 et seq.] by establishing certain requirements for ATSDR and the U.S. Environmental Protection Agency (EPA) regarding the hazardous substances most commonly found at facilities on the CERCLA National Priorities List (NPL). Among these statutory requirements is a mandate for the Administrator of ATSDR to prepare toxicological profiles for each substance included on the priority list of hazardous substances [also called the Substance Priority List (SPL)]. This list identifies 275 hazardous substances that ATSDR and EPA have determined pose the most significant potential threat to human health. The SPL is available online at www.atsdr.cdc.gov/spl. In addition, CERCLA provides ATSDR with the authority to prepare toxicological profiles for substances not found on the SPL. CERCLA authorizes ATSDR to establish and maintain an inventory of literature, research, and studies on the health effects of toxic substances (CERCLA Section 104(i)(1)(B); 42 U.S.C. 9604(i)(1)(B)); to respond to requests for health consultations (CERCLA Section 104(i)(4); 42 U.S.C. 9604(i)(4)); and to support the site-specific response actions conducted by the agency. Availability The Draft Toxicological Profile for Ethylene Oxide will be available online at https://www.atsdr.cdc.gov/ToxProfiles VerDate Sep<11>2014 17:36 Sep 29, 2020 Jkt 250001 and at www.regulations.gov, Docket No. ATSDR–2016–0004. Donata Green, Acting Director, Office of Policy, Planning, and Partnerships, Agency for Toxic Substances and Disease Registry. [FR Doc. 2020–21619 Filed 9–29–20; 8:45 am] BILLING CODE 4163–70–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [60Day–20–1242; Docket No. CDC–2020– 0099] Proposed Data Collection Submitted for Public Comment and Recommendations Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: The Centers for Disease Control and Prevention (CDC), as part of its continuing effort to reduce public burden and maximize the utility of government information, invites the general public and other Federal agencies the opportunity to comment on a proposed and/or continuing information collection, as required by the Paperwork Reduction Act of 1995. This notice invites comment on a proposed information collection project titled Strengthening U.S. Response to Resistant Gonorrhea, which is to intended to enhance U.S. state and local public health surveillance and program infrastructure, build capacity to support rapid detection and public health response to antibiotic-resistant gonorrhea (an urgent public health threat), and advance the understanding of epidemiological factors contributing to antibiotic-resistant gonorrhea. CDC is requesting a three-year approval. DATES: CDC must receive written comments on or before November 30, 2020. SUMMARY: You may submit comments, identified by Docket No. CDC–2020– 0099 by any of the following methods: • Federal eRulemaking Portal: Regulations.gov. Follow the instructions for submitting comments. • Mail: Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS–D74, Atlanta, Georgia 30329. Instructions: All submissions received must include the agency name and Docket Number. CDC will post, without ADDRESSES: PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 change, all relevant comments to Regulations.gov. Please note: Submit all comments through the Federal eRulemaking portal (regulations.gov) or by U.S. mail to the address listed above. FOR FURTHER INFORMATION CONTACT: To request more information on the proposed project or to obtain a copy of the information collection plan and instruments, contact Jeffrey M. Zirger, Information Collection Review Office, Centers for Disease Control and Prevention, 1600 Clifton Road NE, MS– D74, Atlanta, Georgia 30329; phone: 404–639–7570; Email: omb@cdc.gov. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. In addition, the PRA also requires Federal agencies to provide a 60-day notice in the Federal Register concerning each proposed collection of information, including each new proposed collection, each proposed extension of existing collection of information, and each reinstatement of previously approved information collection before submitting the collection to the OMB for approval. To comply with this requirement, we are publishing this notice of a proposed data collection as described below. The OMB is particularly interested in comments that will help: 1. Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; 2. Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; 3. Enhance the quality, utility, and clarity of the information to be collected; and 4. Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submissions of responses. 5. Assess information collection costs. Proposed Project Strengthening U.S. Response to Resistant Gonorrhea (SURRG) (OMB Control No. 0920–1242, Exp. 9/30/ E:\FR\FM\30SEN1.SGM 30SEN1 61751 Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices 2021)—Revision—National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention (CDC). Background and Brief Description The purposes of this Revision request for Strengthening U.S. Response to Resistant Gonorrhea (SURRG) are to: (1) Improve national, state, and local capacity to rapidly detect, monitor, and respond to emerging antibiotic-resistant gonorrhea (and get actionable information to local health departments), (2) understand trends in and factors contributing to antibioticresistant gonorrhea, and (3) build a robust evidence base for public health action. This information collection is important because: (1) Effective treatment of gonorrhea is critical to gonorrhea control and prevention, (2) untreated or inadequately treated gonorrhea can cause serious reproductive health complications, such as infertility, (3) Neisseria gonorrhoeae (the bacterium that causes gonorrhea) has consistently demonstrated the ability to develop antibiotic resistance and may be developing resistance to the last remaining treatment option recommended by the Centers for Disease Control and Prevention (CDC), and (4) antibiotic-resistant gonorrhea is extremely difficult to detect without enhanced surveillance and public health activities, such as SURRG, because healthcare providers rarely perform or have access to culture and resistance testing for individual patients. Jurisdictions participating in SURRG applied as part of a competitive process and will participate voluntarily. As an overview of SURRG, healthcare providers at participating clinics collect specimens for N. gonorrhoeae culture (approximately three hours every two months). Microbiologists at public health laboratories from each funded jurisdiction conduct resistance testing on ∼700 N. gonorrhoeae isolates each year (600 clinical isolates and 100 control strains; each test ∼10 minutes). Laboratory data managers take about one hour every two months to abstract, clean, and transmit data. Health department staff will interview: Any person diagnosed with antibiotic-resistant gonorrhea or have a case of gonorrhea of public health significance index case, and their sexual contacts. On average, each jurisdiction will identify four drug-resistant isolates each month; these isolates will spur field investigations and six additional interviews monthly. We estimate a total of 120 interviews annually at each site, for a total across the eight sites of 960 interviews each year. Each interview will take ∼20 minutes. The total estimated annual burden hours are 2,665. This burden represents a decrease from the burden of the initial submission. The number of jurisdictions decreased from nine to eight. So the number of local data managers decreased from nine to eight (and the burden hours decreased from 1008 to 896), the number of public health microbiologists decreased from nine to eight (burden hours decreased from 1050 to 933), the number of lab data managers decreased from nine to eight (burden hours decreased from 54 to 48), and the number of gonorrhea and contacts decreased from 1080 to 960 (burden hours decreased from 540 to 480). The number of clinic sites will increase from 18 to 26. Respondents receive federal funds to participate in this project. There are no additional costs to respondents other than their time. testing. Specimens that demonstrate N. gonorrhoeae (called ‘‘isolates’’) rapidly undergo antibiotic resistance testing at the local public health laboratory. Detection of resistance is rapidly communicated by laboratory staff to the healthcare provider and health department. The patient (from whom the resistant specimen was collected) is interviewed by local health department staff about risk factors and recent contacts, and will be re-tested to ensure that they were cured. Recent contacts are interviewed by the health department (contact tracing) and tested for gonorrhea. The participating health departments collect and transmit to CDC demographic and clinical data about persons tested for and diagnosed with gonorrhea in the participating clinics, results of local antibiotic resistance testing, and information about field investigations. None of the data transmitted to CDC contains any personally identifiable information. These data are used by CDC to monitor and better understand resistance and identify effective approaches to prevent resistance spread. Data are transmitted to CDC through a secure encrypted file transfer application and stored in a secure CDC server with strictly controlled and restricted access rights. In processes that take approximately 16 hours every two months (plus an annual cumulative datafile), local SURRG data managers abstract STD clinic data for patients tested for gonorrhea and field investigation data, receive gonorrhea data from non-STD clinic healthcare sites and resistance testing results from local public health laboratories, and clean and transmit data to CDC. Other data managers at each participating non-STD clinic health center abstract, clean, and transmit data jbell on DSKJLSW7X2PROD with NOTICES ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Number of respondents Average burden per response (hours) Total burden hours Type of respondent Form name Local SURRG data manager ............ Data manager at non-STD clinic health centers. Public Health Laboratory Microbiologist. Public Health Laboratory Data Manager. Gonorrhea Patients, Social and Sexual Contacts. STD Clinic Facility Data Elements ... Non-STD Clinic Facility Data Elements. Laboratory Data Elements ............... 8 26 7 6 16 3 896 468 8 700 10/60 933 Laboratory Testing Data Elements .. 8 6 1 48 Investigation Data Elements ............ 960 1 0.33 320 Total ........................................... ........................................................... ........................ ........................ ........................ 2,665 VerDate Sep<11>2014 17:36 Sep 29, 2020 Jkt 250001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\30SEN1.SGM 30SEN1 61752 Federal Register / Vol. 85, No. 190 / Wednesday, September 30, 2020 / Notices Jeffery M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2020–21621 Filed 9–29–20; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— DD21–001, Study to Explore Early Development (SEED) Follow up Studies. Date: January 12–13, 2021. Time: 10:00 a.m.–6:00 p.m., EST. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop S107–8, Atlanta, Georgia 30341, Telephone: (770) 488–6511, JRaman@ cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–21604 Filed 9–29–20; 8:45 am] decision concerning the collection of information between 30 and 60 days after publication of this document in the Federal Register. Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent within 30 days of publication of this notice to www.reginfo.gov/public/do/ PRAMain. Find this particular information collection by selecting ‘‘Currently under 30-day Review—Open for Public Comments’’ or by using the search function. ADDRESSES: SUPPLEMENTARY INFORMATION: BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (NAC) Recommendations and State SelfAssessment Survey (NEW) Office on Trafficking in Persons, Administration for Children and Families, HHS. ACTION: Request for public comment. AGENCY: The Office on Trafficking in Persons (OTIP), Administration for Children and Families (ACF), U.S. Department of Health and Human Services (HHS), is proposing to collect data for a new survey, the National Advisory Committee on the Sex Trafficking of Children and Youth in the United States (NAC) Recommendations and State Self-Assessment Survey. DATES: Comments due within 30 days of publication. OMB is required to make a SUMMARY: Description: The Preventing Sex Trafficking and Strengthening Families Act of 2014 mandated the NAC to develop a report describing how each state and territory has implemented its recommendations to address sex trafficking in children and youth. The NAC proposes to administer a survey allowing states to assess their progress in implementing NAC recommendations. Submissions will allow states to document their efforts in the following sections: Multidisciplinary Response, Screening and Identification, Child Welfare, Service Provision, Housing, Law Enforcement and Prosecution, Judiciary, Demand Reduction, Prevention, Legislation and Regulation, Research and Data, and Funding. Each state will have the opportunity to provide a selfassessed tier ranking for each recommendation, a justification of their assessment, sources for their assessment, and the public or private nature of those sources. Respondents: State Governors, Child Welfare Agencies, Local Law Enforcement, and Other Local Agencies. Annual Burden Estimates: ESTIMATED OPPORTUNITY COSTS FOR RESPONDENTS Instrument Total number of respondents contributing for 50 states Total number of responses per respondent 250 1 jbell on DSKJLSW7X2PROD with NOTICES NAC Recommendations and State Self-Assessment Survey ....................... Estimated Total Annual Burden Hours: 1,713. VerDate Sep<11>2014 17:36 Sep 29, 2020 Jkt 250001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\30SEN1.SGM 30SEN1 Average burden hours per response 6.85 Total/annual burden hours 1,713

Agencies

[Federal Register Volume 85, Number 190 (Wednesday, September 30, 2020)]
[Notices]
[Pages 61750-61752]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-21621]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-20-1242; Docket No. CDC-2020-0099]


Proposed Data Collection Submitted for Public Comment and 
Recommendations

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice with comment period.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), as part 
of its continuing effort to reduce public burden and maximize the 
utility of government information, invites the general public and other 
Federal agencies the opportunity to comment on a proposed and/or 
continuing information collection, as required by the Paperwork 
Reduction Act of 1995. This notice invites comment on a proposed 
information collection project titled Strengthening U.S. Response to 
Resistant Gonorrhea, which is to intended to enhance U.S. state and 
local public health surveillance and program infrastructure, build 
capacity to support rapid detection and public health response to 
antibiotic-resistant gonorrhea (an urgent public health threat), and 
advance the understanding of epidemiological factors contributing to 
antibiotic-resistant gonorrhea. CDC is requesting a three-year 
approval.

DATES: CDC must receive written comments on or before November 30, 
2020.

ADDRESSES: You may submit comments, identified by Docket No. CDC-2020-
0099 by any of the following methods:
     Federal eRulemaking Portal: Regulations.gov. Follow the 
instructions for submitting comments.
     Mail: Jeffrey M. Zirger, Information Collection Review 
Office, Centers for Disease Control and Prevention, 1600 Clifton Road 
NE, MS-D74, Atlanta, Georgia 30329.
    Instructions: All submissions received must include the agency name 
and Docket Number. CDC will post, without change, all relevant comments 
to Regulations.gov.
    Please note: Submit all comments through the Federal eRulemaking 
portal (regulations.gov) or by U.S. mail to the address listed above.

FOR FURTHER INFORMATION CONTACT: To request more information on the 
proposed project or to obtain a copy of the information collection plan 
and instruments, contact Jeffrey M. Zirger, Information Collection 
Review Office, Centers for Disease Control and Prevention, 1600 Clifton 
Road NE, MS-D74, Atlanta, Georgia 30329; phone: 404-639-7570; Email: 
[email protected].

SUPPLEMENTARY INFORMATION: 
    Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501-
3520), Federal agencies must obtain approval from the Office of 
Management and Budget (OMB) for each collection of information they 
conduct or sponsor. In addition, the PRA also requires Federal agencies 
to provide a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each new proposed 
collection, each proposed extension of existing collection of 
information, and each reinstatement of previously approved information 
collection before submitting the collection to the OMB for approval. To 
comply with this requirement, we are publishing this notice of a 
proposed data collection as described below.
    The OMB is particularly interested in comments that will help:
    1. Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    2. Evaluate the accuracy of the agency's estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    3. Enhance the quality, utility, and clarity of the information to 
be collected; and
    4. Minimize the burden of the collection of information on those 
who are to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submissions of responses.
    5. Assess information collection costs.

Proposed Project

    Strengthening U.S. Response to Resistant Gonorrhea (SURRG) (OMB 
Control No. 0920-1242, Exp. 9/30/

[[Page 61751]]

2021)--Revision--National Center for HIV/AIDS, Viral Hepatitis, STD, 
and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention 
(CDC).

Background and Brief Description

    The purposes of this Revision request for Strengthening U.S. 
Response to Resistant Gonorrhea (SURRG) are to: (1) Improve national, 
state, and local capacity to rapidly detect, monitor, and respond to 
emerging antibiotic-resistant gonorrhea (and get actionable information 
to local health departments), (2) understand trends in and factors 
contributing to antibiotic-resistant gonorrhea, and (3) build a robust 
evidence base for public health action. This information collection is 
important because: (1) Effective treatment of gonorrhea is critical to 
gonorrhea control and prevention, (2) untreated or inadequately treated 
gonorrhea can cause serious reproductive health complications, such as 
infertility, (3) Neisseria gonorrhoeae (the bacterium that causes 
gonorrhea) has consistently demonstrated the ability to develop 
antibiotic resistance and may be developing resistance to the last 
remaining treatment option recommended by the Centers for Disease 
Control and Prevention (CDC), and (4) antibiotic-resistant gonorrhea is 
extremely difficult to detect without enhanced surveillance and public 
health activities, such as SURRG, because healthcare providers rarely 
perform or have access to culture and resistance testing for individual 
patients.
    Jurisdictions participating in SURRG applied as part of a 
competitive process and will participate voluntarily. As an overview of 
SURRG, healthcare providers at participating clinics collect specimens 
for N. gonorrhoeae culture testing. Specimens that demonstrate N. 
gonorrhoeae (called ``isolates'') rapidly undergo antibiotic resistance 
testing at the local public health laboratory. Detection of resistance 
is rapidly communicated by laboratory staff to the healthcare provider 
and health department. The patient (from whom the resistant specimen 
was collected) is interviewed by local health department staff about 
risk factors and recent contacts, and will be re-tested to ensure that 
they were cured. Recent contacts are interviewed by the health 
department (contact tracing) and tested for gonorrhea. The 
participating health departments collect and transmit to CDC 
demographic and clinical data about persons tested for and diagnosed 
with gonorrhea in the participating clinics, results of local 
antibiotic resistance testing, and information about field 
investigations. None of the data transmitted to CDC contains any 
personally identifiable information. These data are used by CDC to 
monitor and better understand resistance and identify effective 
approaches to prevent resistance spread. Data are transmitted to CDC 
through a secure encrypted file transfer application and stored in a 
secure CDC server with strictly controlled and restricted access 
rights.
    In processes that take approximately 16 hours every two months 
(plus an annual cumulative datafile), local SURRG data managers 
abstract STD clinic data for patients tested for gonorrhea and field 
investigation data, receive gonorrhea data from non-STD clinic 
healthcare sites and resistance testing results from local public 
health laboratories, and clean and transmit data to CDC.
    Other data managers at each participating non-STD clinic health 
center abstract, clean, and transmit data (approximately three hours 
every two months). Microbiologists at public health laboratories from 
each funded jurisdiction conduct resistance testing on ~700 N. 
gonorrhoeae isolates each year (600 clinical isolates and 100 control 
strains; each test ~10 minutes). Laboratory data managers take about 
one hour every two months to abstract, clean, and transmit data.
    Health department staff will interview: Any person diagnosed with 
antibiotic-resistant gonorrhea or have a case of gonorrhea of public 
health significance index case, and their sexual contacts. On average, 
each jurisdiction will identify four drug-resistant isolates each 
month; these isolates will spur field investigations and six additional 
interviews monthly. We estimate a total of 120 interviews annually at 
each site, for a total across the eight sites of 960 interviews each 
year. Each interview will take ~20 minutes.
    The total estimated annual burden hours are 2,665. This burden 
represents a decrease from the burden of the initial submission. The 
number of jurisdictions decreased from nine to eight. So the number of 
local data managers decreased from nine to eight (and the burden hours 
decreased from 1008 to 896), the number of public health 
microbiologists decreased from nine to eight (burden hours decreased 
from 1050 to 933), the number of lab data managers decreased from nine 
to eight (burden hours decreased from 54 to 48), and the number of 
gonorrhea and contacts decreased from 1080 to 960 (burden hours 
decreased from 540 to 480). The number of clinic sites will increase 
from 18 to 26. Respondents receive federal funds to participate in this 
project. There are no additional costs to respondents other than their 
time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
      Type of respondent            Form name        Number of     responses per   per response    Total burden
                                                    respondents     respondent        (hours)          hours
----------------------------------------------------------------------------------------------------------------
Local SURRG data manager......  STD Clinic                     8               7              16             896
                                 Facility Data
                                 Elements.
Data manager at non-STD clinic  Non-STD Clinic                26               6               3             468
 health centers.                 Facility Data
                                 Elements.
Public Health Laboratory        Laboratory Data                8             700           10/60             933
 Microbiologist.                 Elements.
Public Health Laboratory Data   Laboratory                     8               6               1              48
 Manager.                        Testing Data
                                 Elements.
Gonorrhea Patients, Social and  Investigation                960               1            0.33             320
 Sexual Contacts.                Data Elements.
                                                 ---------------------------------------------------------------
    Total.....................  ................  ..............  ..............  ..............           2,665
----------------------------------------------------------------------------------------------------------------



[[Page 61752]]

Jeffery M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2020-21621 Filed 9-29-20; 8:45 am]
 BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.